HCPCS J0897
Injection, denosumab, 1 mg (CMS descriptor)
Drugs Drug code Work RVU per service none (2023 fee schedule; adds 0 work RVUs)
Trend
Medicare payment on the code
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Data years 2020–2024.
Billers
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Data years 2020–2024.
| observed | calculated | calculated | calculated | calculated | calculated | reported | |
|---|---|---|---|---|---|---|---|
| 2024 | 9,797 | $978,864,123 | +12% | 48,156,716 | 2,760 | 15,366 | 0.00 |
| 2023 | 10,057 | $875,043,253 | +9% | 48,034,893 | 2,640 | 15,480 | 0.00 |
| 2022 | 10,191 | $804,559,510 | +5% | 47,552,605 | 2,640 | 15,180 | 0.00 |
| 2021 | 9,981 | $763,317,410 | +10% | 46,983,078 | 2,640 | 15,512 | 0.00 |
| 2020 | 9,672 | $696,220,853 | first year in data | 45,291,470 | 2,640 | 15,480 | 0.00 |
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Data years 2020–2024.
By state
| observed | calculated | calculated | calculated | calculated | calculated | |
|---|---|---|---|---|---|---|
| Florida | 1,056 | $112,453,309 | 6,146,448 | 3,291 | 19,275 | |
| California | 1,033 | $94,377,920 | 5,218,817 | 3,060 | 16,296 | |
| Texas | 647 | $51,210,897 | 2,804,040 | 2,580 | 13,062 | |
| Pennsylvania | 526 | $47,110,354 | 2,579,507 | 2,460 | 15,811 | |
| New York | 493 | $41,621,529 | 2,276,920 | 2,820 | 12,600 | |
| Maryland | 340 | $38,904,420 | 2,136,176 | 3,600 | 21,556 | |
| Illinois | 405 | $36,782,226 | 2,016,132 | 2,520 | 15,642 | |
| New Jersey | 379 | $33,279,974 | 1,826,369 | 3,060 | 13,068 | |
| Virginia | 342 | $30,540,427 | 1,675,233 | 2,820 | 13,854 | |
| Arizona | 257 | $29,697,605 | 1,625,127 | 2,940 | 24,192 | |
| North Carolina | 431 | $27,532,119 | 1,509,503 | 2,100 | 10,530 | |
| Georgia | 292 | $26,336,920 | 1,456,555 | 2,460 | 16,737 | |
| South Carolina | 245 | $22,348,680 | 1,227,455 | 2,400 | 20,988 | |
| Tennessee | 243 | $20,648,589 | 1,131,248 | 2,940 | 14,550 | |
| Alabama | 198 | $19,342,975 | 1,072,800 | 3,120 | 17,832 |
Not listed: 1 billers with an armed-forces or unknown state code (XX); they are in the national totals.
Not listed: 4 states with fewer than 11 billers (small cells).
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Providers placed by practice address. Data year 2023.
Top metro areas
| observed | calculated | calculated | calculated | calculated | |
|---|---|---|---|---|---|
| New York-Newark-Jersey City, NY-NJ | 624 | $55,539,624 | 3,045,863 | 2,820 | |
| Los Angeles-Long Beach-Anaheim, CA | 370 | $30,851,907 | 1,718,422 | 3,150 | |
| Philadelphia-Camden-Wilmington, PA-NJ-DE-MD | 272 | $28,388,929 | 1,551,162 | 4,020 | |
| Chicago-Naperville-Elgin, IL-IN | 305 | $26,666,172 | 1,459,941 | 2,520 | |
| Washington-Arlington-Alexandria, DC-VA-MD-WV | 221 | $24,934,992 | 1,374,725 | 3,720 | |
| Miami-Fort Lauderdale-West Palm Beach, FL | 166 | $23,948,163 | 1,315,998 | 4,080 | |
| Phoenix-Mesa-Chandler, AZ | 168 | $18,402,711 | 1,005,561 | 2,610 | |
| Baltimore-Columbia-Towson, MD | 166 | $16,343,776 | 895,649 | 2,910 | |
| Tampa-St. Petersburg-Clearwater, FL | 149 | $14,564,384 | 792,970 | 3,480 | |
| Dallas-Fort Worth-Arlington, TX | 189 | $14,054,222 | 768,747 | 2,280 | |
| North Port-Bradenton-Sarasota, FL | 85 | $12,544,088 | 685,343 | 6,060 | |
| San Francisco-Oakland-Fremont, CA | 139 | $11,439,119 | 645,125 | 3,660 | |
| Atlanta-Sandy Springs-Roswell, GA | 163 | $11,053,860 | 615,458 | 2,220 | |
| Houston-Pasadena-The Woodlands, TX | 129 | $9,972,202 | 545,842 | 3,060 | |
| Virginia Beach-Chesapeake-Norfolk, VA-NC | 89 | $9,502,776 | 518,944 | 3,780 |
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). The 95 areas with the most payment among those with at least 11 billers; non-metro parts of each state are one area. Data year 2023.
Specialties billing J0897 nationally
Hematology-Oncology accounts for 26% of payment for J0897 nationally in 2023, across 23 specialties on claims.
| observed | calculated | calculated | calculated | calculated | calculated | |
|---|---|---|---|---|---|---|
| Hematology-Oncology | 1,768 | 18% | $225,101,152 | 26% | 12,330,813 | 6,974 |
| Rheumatology | 1,811 | 18% | $219,065,936 | 25% | 11,997,537 | 6,625 |
| Internal Medicine | 1,570 | 16% | $79,340,629 | 9.1% | 4,381,644 | 2,791 |
| Nurse Practitioner | 1,005 | 10.0% | $79,082,828 | 9.0% | 4,332,825 | 4,311 |
| Endocrinology | 998 | 9.9% | $72,118,539 | 8.2% | 3,969,509 | 3,977 |
| Medical Oncology | 499 | 5.0% | $59,330,765 | 6.8% | 3,257,535 | 6,528 |
| Family Practice | 1,164 | 12% | $44,016,015 | 5.0% | 2,441,808 | 2,098 |
| Physician Assistant | 352 | 3.5% | $28,006,881 | 3.2% | 1,538,348 | 4,370 |
| Urology | 283 | 2.8% | $23,223,709 | 2.7% | 1,266,634 | 4,476 |
| Obstetrics & Gynecology | 212 | 2.1% | $9,997,913 | 1.1% | 551,652 | 2,602 |
| Infectious Disease | 65 | 0.65% | $7,535,263 | 0.86% | 414,074 | 6,370 |
| Hematology | 44 | 0.44% | $5,773,738 | 0.66% | 314,368 | 7,145 |
| Orthopedic Surgery | 51 | 0.51% | $4,585,391 | 0.52% | 257,044 | 5,040 |
| Gastroenterology | 16 | 0.16% | $1,731,757 | 0.20% | 94,034 | 5,877 |
| General Practice | 21 | 0.21% | $1,600,175 | 0.18% | 88,492 | 4,214 |
Not listed: 18 specialties with fewer than 11 billers (small cells).
Source: CMS Medicare Physician & Other Practitioners public use files (Original Medicare Part B fee-for-service). Provider-level lines (fewer than 11 beneficiaries suppressed by CMS); specialty is the provider type on claims. Data year 2023.
Top billers of J0897 nationally
Named top billers are a Pro figure, and Pro is not available to buy, so this list is not shown to any account. The counts and totals by state, metro area and specialty on this page are free.
Original Medicare Part B fee-for-service only; CMS suppresses provider lines with fewer than 11 beneficiaries. How these figures are computed · Limitations